Halozyme Therapeutics Inc (HALO)

[jamtomorrow2]

I was looking at the historical likelihood of approval figures in oncology on this site

https://www.bio.org/sites/default/files/Clinical%20Development%20Success%20Rates%202006-2015%20-%20BIO,%20Biomedtracker,%20Amplion%202016.pdf

It's quite interesting that in oncology there is only an 8.1% chance of going from a Phase 2 trial to FDA approval and only a 33% chance of going from Phase 3 to FDA approval. In solid tumours these rates decrease to 6.3% and 27.3% respectively. And in pancreatic cancer it looks from one of the charts that the figure from Phase 3 to FDA approval is only about 16%. I expect these figures would be even lower for companies of HALO's market cap.

So when analysts are now suggesting that PEG has a 60% chance of being approved for Pancreatic Cancer that is statistically significant!